Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Lack of CMO availability threatens cell and gene therapy development
  2. CD47-targeted therapies: the breast cancer mop?
  3. Through CRISPR gene editing we can change the nature of our species
  4. Could groundbreaking gene therapies offer a breakthrough to retinal disease sufferers?
  5. Could a new gene-editing technology permanently cure Duchenne muscular dystrophy?

Latest Content

From Gene to Finished Vial

Biovian is a one-stop-shop in GMP contract manufacturing of biopharmaceuticals, covering services from early development to finished vial.

B&W Tek

This video is about the services that B&W Tek offers.

The age of immortality

For the first time in human history the possibility of immortality, or at least drastically prolonged lifespans, is real.

Through CRISPR gene editing we can change the nature of our species

In 2018, we can expect to see large numbers of CRISPR trials taking off all over the world and we should not be afraid of this technology, because we severely need it if we want to cure chronic disease or change our nature to better cope with a changing environment and new challenges for our species.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top